Clinical Drug Interaction Studies — Study Design, Data Analysis, and Clinical Implications Guidance for Industry

This guidance helps sponsors of investigational new drug applications and applicants of new drug 17 applications evaluate drug-drug interactions (DDIs) during drug development and communicate 18 the results and recommendations from DDI studies.

Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news